Evaluation of the Drug-Resistant Tuberculosis in Kerala, India, 2021-22
Background and Objective: We evaluated the DR-TB component of the National Tuberculosis Elimination Program (NTEP) in a high-burden district in Kerala to identify the programmatic gaps, if any, in screening, diagnosis, treatment, and follow-up of notified DR-TB patients. Methods: A mixed-methods des...
Gespeichert in:
Veröffentlicht in: | Lung India 2025-01, Vol.42 (1), p.16 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 1 |
container_start_page | 16 |
container_title | Lung India |
container_volume | 42 |
creator | Vaman, Raman Swathy Kalyanasundaram, Madhanraj Mohan, Malu Pradeepa, Narayana Murhekar, Manoj V |
description | Background and Objective: We evaluated the DR-TB component of the National Tuberculosis Elimination Program (NTEP) in a high-burden district in Kerala to identify the programmatic gaps, if any, in screening, diagnosis, treatment, and follow-up of notified DR-TB patients. Methods: A mixed-methods design was used, and the evaluation was performed in two steps. In the first step, we reviewed the program documents and conducted stakeholder interviews to develop a detailed description of the program design and developed a logical framework to evaluate program performance. Consequently, in the next step, we conducted programmatic data reviews, facility surveys, and in-depth interviews with key stakeholders to identify the programmatic gaps in implementation, guided by the logic framework. Results: Of the 494 microbiologically confirmed TB patients during 2021-22, 342 (69%) were tested for drug sensitivity, and 30 DR-TB patients were identified. There was no separate district DR-TB treatment center with airborne infection control facilities, and only 16% (66/422) of the various categories of staff were trained in recent guidelines. Only 30% (9/30) of DR-TB patients were provided with any psychological assessment. The favorable treatment outcome was 80% Interviews revealed poor readiness and motivation from the private sector for screening, contextual barriers in human resource availability, transportation, and financial barriers to the beneficiary despite providing financial benefits. Conclusion: Prioritizing the establishment of a district DR-TB treatment center and sputum transport mechanism, posting a clinical psychologist dedicated to counseling patients on therapy, and training all categories of staff on DR-TB management guidelines will significantly contribute to improving program outcomes. Keywords: India, logic framework model, multidrug-resistant tuberculosis, program evaluation |
doi_str_mv | 10.4103/lungindia.lungindia_355_24 |
format | Article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A821149792</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A821149792</galeid><sourcerecordid>A821149792</sourcerecordid><originalsourceid>FETCH-LOGICAL-g672-450599ba517e786123eb75cb8c5ce936567d695de39ffcf198e89d07fdd000a43</originalsourceid><addsrcrecordid>eNptj0tLAzEUhbNQsFb_Q9BtU_POZFlqrcWCILMfMsnNGJlmYB7-fkeU4kLO4h4O372Xg9Ado2vJqHhop9ykHJJbn10llKq4vEALag0lnDFxha6H4YNSLRUTC7Tffbp2cmPqMu4iHt8BP_ZTQ95gSMPo8ojLqYbeT203Bzhl_AK9a90KH74frDCnnBHOb9BldO0At79zicqnXbl9JsfX_WG7OZJGG06kosra2ilmwBSacQG1Ub4uvPJghVbaBG1VAGFj9JHZAgobqIkhUEqdFEt0_3O2cS1UKcdu7J0_pcFXm2KuJ62xfKbW_1CzApyS7zLENOd_Fr4Afkde1w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Evaluation of the Drug-Resistant Tuberculosis in Kerala, India, 2021-22</title><source>Medknow Open Access Medical Journals</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Vaman, Raman Swathy ; Kalyanasundaram, Madhanraj ; Mohan, Malu ; Pradeepa, Narayana ; Murhekar, Manoj V</creator><creatorcontrib>Vaman, Raman Swathy ; Kalyanasundaram, Madhanraj ; Mohan, Malu ; Pradeepa, Narayana ; Murhekar, Manoj V</creatorcontrib><description>Background and Objective: We evaluated the DR-TB component of the National Tuberculosis Elimination Program (NTEP) in a high-burden district in Kerala to identify the programmatic gaps, if any, in screening, diagnosis, treatment, and follow-up of notified DR-TB patients. Methods: A mixed-methods design was used, and the evaluation was performed in two steps. In the first step, we reviewed the program documents and conducted stakeholder interviews to develop a detailed description of the program design and developed a logical framework to evaluate program performance. Consequently, in the next step, we conducted programmatic data reviews, facility surveys, and in-depth interviews with key stakeholders to identify the programmatic gaps in implementation, guided by the logic framework. Results: Of the 494 microbiologically confirmed TB patients during 2021-22, 342 (69%) were tested for drug sensitivity, and 30 DR-TB patients were identified. There was no separate district DR-TB treatment center with airborne infection control facilities, and only 16% (66/422) of the various categories of staff were trained in recent guidelines. Only 30% (9/30) of DR-TB patients were provided with any psychological assessment. The favorable treatment outcome was 80% Interviews revealed poor readiness and motivation from the private sector for screening, contextual barriers in human resource availability, transportation, and financial barriers to the beneficiary despite providing financial benefits. Conclusion: Prioritizing the establishment of a district DR-TB treatment center and sputum transport mechanism, posting a clinical psychologist dedicated to counseling patients on therapy, and training all categories of staff on DR-TB management guidelines will significantly contribute to improving program outcomes. Keywords: India, logic framework model, multidrug-resistant tuberculosis, program evaluation</description><identifier>ISSN: 0970-2113</identifier><identifier>DOI: 10.4103/lungindia.lungindia_355_24</identifier><language>eng</language><publisher>Medknow Publications and Media Pvt. Ltd</publisher><subject>Antitubercular agents ; Drug resistance in microorganisms ; Drug therapy ; Evaluation ; Health aspects ; Patient compliance ; Surveys ; Tuberculosis</subject><ispartof>Lung India, 2025-01, Vol.42 (1), p.16</ispartof><rights>COPYRIGHT 2025 Medknow Publications and Media Pvt. Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Vaman, Raman Swathy</creatorcontrib><creatorcontrib>Kalyanasundaram, Madhanraj</creatorcontrib><creatorcontrib>Mohan, Malu</creatorcontrib><creatorcontrib>Pradeepa, Narayana</creatorcontrib><creatorcontrib>Murhekar, Manoj V</creatorcontrib><title>Evaluation of the Drug-Resistant Tuberculosis in Kerala, India, 2021-22</title><title>Lung India</title><description>Background and Objective: We evaluated the DR-TB component of the National Tuberculosis Elimination Program (NTEP) in a high-burden district in Kerala to identify the programmatic gaps, if any, in screening, diagnosis, treatment, and follow-up of notified DR-TB patients. Methods: A mixed-methods design was used, and the evaluation was performed in two steps. In the first step, we reviewed the program documents and conducted stakeholder interviews to develop a detailed description of the program design and developed a logical framework to evaluate program performance. Consequently, in the next step, we conducted programmatic data reviews, facility surveys, and in-depth interviews with key stakeholders to identify the programmatic gaps in implementation, guided by the logic framework. Results: Of the 494 microbiologically confirmed TB patients during 2021-22, 342 (69%) were tested for drug sensitivity, and 30 DR-TB patients were identified. There was no separate district DR-TB treatment center with airborne infection control facilities, and only 16% (66/422) of the various categories of staff were trained in recent guidelines. Only 30% (9/30) of DR-TB patients were provided with any psychological assessment. The favorable treatment outcome was 80% Interviews revealed poor readiness and motivation from the private sector for screening, contextual barriers in human resource availability, transportation, and financial barriers to the beneficiary despite providing financial benefits. Conclusion: Prioritizing the establishment of a district DR-TB treatment center and sputum transport mechanism, posting a clinical psychologist dedicated to counseling patients on therapy, and training all categories of staff on DR-TB management guidelines will significantly contribute to improving program outcomes. Keywords: India, logic framework model, multidrug-resistant tuberculosis, program evaluation</description><subject>Antitubercular agents</subject><subject>Drug resistance in microorganisms</subject><subject>Drug therapy</subject><subject>Evaluation</subject><subject>Health aspects</subject><subject>Patient compliance</subject><subject>Surveys</subject><subject>Tuberculosis</subject><issn>0970-2113</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptj0tLAzEUhbNQsFb_Q9BtU_POZFlqrcWCILMfMsnNGJlmYB7-fkeU4kLO4h4O372Xg9Ado2vJqHhop9ykHJJbn10llKq4vEALag0lnDFxha6H4YNSLRUTC7Tffbp2cmPqMu4iHt8BP_ZTQ95gSMPo8ojLqYbeT203Bzhl_AK9a90KH74frDCnnBHOb9BldO0At79zicqnXbl9JsfX_WG7OZJGG06kosra2ilmwBSacQG1Ub4uvPJghVbaBG1VAGFj9JHZAgobqIkhUEqdFEt0_3O2cS1UKcdu7J0_pcFXm2KuJ62xfKbW_1CzApyS7zLENOd_Fr4Afkde1w</recordid><startdate>20250101</startdate><enddate>20250101</enddate><creator>Vaman, Raman Swathy</creator><creator>Kalyanasundaram, Madhanraj</creator><creator>Mohan, Malu</creator><creator>Pradeepa, Narayana</creator><creator>Murhekar, Manoj V</creator><general>Medknow Publications and Media Pvt. Ltd</general><scope/></search><sort><creationdate>20250101</creationdate><title>Evaluation of the Drug-Resistant Tuberculosis in Kerala, India, 2021-22</title><author>Vaman, Raman Swathy ; Kalyanasundaram, Madhanraj ; Mohan, Malu ; Pradeepa, Narayana ; Murhekar, Manoj V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g672-450599ba517e786123eb75cb8c5ce936567d695de39ffcf198e89d07fdd000a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Antitubercular agents</topic><topic>Drug resistance in microorganisms</topic><topic>Drug therapy</topic><topic>Evaluation</topic><topic>Health aspects</topic><topic>Patient compliance</topic><topic>Surveys</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vaman, Raman Swathy</creatorcontrib><creatorcontrib>Kalyanasundaram, Madhanraj</creatorcontrib><creatorcontrib>Mohan, Malu</creatorcontrib><creatorcontrib>Pradeepa, Narayana</creatorcontrib><creatorcontrib>Murhekar, Manoj V</creatorcontrib><jtitle>Lung India</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vaman, Raman Swathy</au><au>Kalyanasundaram, Madhanraj</au><au>Mohan, Malu</au><au>Pradeepa, Narayana</au><au>Murhekar, Manoj V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the Drug-Resistant Tuberculosis in Kerala, India, 2021-22</atitle><jtitle>Lung India</jtitle><date>2025-01-01</date><risdate>2025</risdate><volume>42</volume><issue>1</issue><spage>16</spage><pages>16-</pages><issn>0970-2113</issn><abstract>Background and Objective: We evaluated the DR-TB component of the National Tuberculosis Elimination Program (NTEP) in a high-burden district in Kerala to identify the programmatic gaps, if any, in screening, diagnosis, treatment, and follow-up of notified DR-TB patients. Methods: A mixed-methods design was used, and the evaluation was performed in two steps. In the first step, we reviewed the program documents and conducted stakeholder interviews to develop a detailed description of the program design and developed a logical framework to evaluate program performance. Consequently, in the next step, we conducted programmatic data reviews, facility surveys, and in-depth interviews with key stakeholders to identify the programmatic gaps in implementation, guided by the logic framework. Results: Of the 494 microbiologically confirmed TB patients during 2021-22, 342 (69%) were tested for drug sensitivity, and 30 DR-TB patients were identified. There was no separate district DR-TB treatment center with airborne infection control facilities, and only 16% (66/422) of the various categories of staff were trained in recent guidelines. Only 30% (9/30) of DR-TB patients were provided with any psychological assessment. The favorable treatment outcome was 80% Interviews revealed poor readiness and motivation from the private sector for screening, contextual barriers in human resource availability, transportation, and financial barriers to the beneficiary despite providing financial benefits. Conclusion: Prioritizing the establishment of a district DR-TB treatment center and sputum transport mechanism, posting a clinical psychologist dedicated to counseling patients on therapy, and training all categories of staff on DR-TB management guidelines will significantly contribute to improving program outcomes. Keywords: India, logic framework model, multidrug-resistant tuberculosis, program evaluation</abstract><pub>Medknow Publications and Media Pvt. Ltd</pub><doi>10.4103/lungindia.lungindia_355_24</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0970-2113 |
ispartof | Lung India, 2025-01, Vol.42 (1), p.16 |
issn | 0970-2113 |
language | eng |
recordid | cdi_gale_infotracmisc_A821149792 |
source | Medknow Open Access Medical Journals; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access |
subjects | Antitubercular agents Drug resistance in microorganisms Drug therapy Evaluation Health aspects Patient compliance Surveys Tuberculosis |
title | Evaluation of the Drug-Resistant Tuberculosis in Kerala, India, 2021-22 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A38%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20Drug-Resistant%20Tuberculosis%20in%20Kerala,%20India,%202021-22&rft.jtitle=Lung%20India&rft.au=Vaman,%20Raman%20Swathy&rft.date=2025-01-01&rft.volume=42&rft.issue=1&rft.spage=16&rft.pages=16-&rft.issn=0970-2113&rft_id=info:doi/10.4103/lungindia.lungindia_355_24&rft_dat=%3Cgale%3EA821149792%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A821149792&rfr_iscdi=true |